H100 Group ABNGM:H100 +0.91%33 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates NGM:H100 with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 665 Healthcare Providers & Services companies, H100 Group AB ranks worse than 92.03% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. H100 Group AB's EBITDA for the
six
months ended in Dec. 2025 was kr0.00 Mil. H100 Group AB's Revenue for the
six
months ended in Dec. 2025 was kr0.00 Mil. Therefore, H100 Group AB's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.
H100 Group AB (NGM:H100) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
H100 Group AB EBITDA Margin % Related Terms
H100 Group AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for H100 Group AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:H100 vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, H100 Group AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H100 Group AB EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, H100 Group AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where H100 Group AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H100 Group AB (NGM:H100) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on H100 Group AB and its competitors. According to the industry distribution chart, H100 Group AB ranks #612 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 92%.
Is H100 Group AB's EBITDA Margin % too high?
H100 Group AB's current EBITDA Margin % is 0.00%. Based on the distribution chart, H100 Group AB ranks #612 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, H100 Group AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does H100 Group AB's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, H100 Group AB ranks #612 out of 665 companies for EBITDA Margin %. This places H100 Group AB in the lower half of its industry. The industry median EBITDA Margin % is 10.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.19, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on H100 Group AB and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H100 Group AB's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H100 Group AB stock overvalued right now?
H100 Group AB (NGM:H100) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. H100 Group AB's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For H100 Group AB (NGM:H100), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
H100 Group AB is a Swedish health technology company and the Bitcoin Treasury Company in the Nordics. The Company's objective is to maximize Bitcoin exposure per share by expanding its Bitcoin treasury through financial instruments. The Company operates through two business areas: Bitcoin Treasury operations, which focus on increasing Bitcoin exposure per share through strategic and financial instruments, and a health-tech division that supports health and longevity providers with AI-powered automation and growth tools. The Company generates revenue from digital services related to training and nutrition coaching provided to B2C customers and SaaS revenue related to the Group's digital platform provided to B2B customers. It operates in Sweden and Norway.
33GF Score
Get the complete analysis for NGM:H100
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:H100 has been successfully added to your 
